Page 40 - ebook HCC
P. 40



38 PROGRAMME AND ABSTRACTS GENEVA, SWITZERLAND EASL HCC SUMMIT 39
FEBRUARY 13 - 16, 2014










# Title Last name First Name # Title Last name First Name

PREDICTIVE BIOMARKER FOR SORAFENIB MANAGEMENT OF INTERMEDIATE STAGE
C78 Honda Takuya
THERAPY IN HEPATOCELLULAR CARCINOMA OF HCC: A COMPARISON BETWEEN
C88 Patti Riccardo
ROLE OF THE ERK5 SIGNALLING IN THE CONVENTIONAL AND DRUG-ELUTING
C79 Di Maira Giovanni BEADS TACE
HUMAN HEPATOCELLULAR CARCINOMA
GENETIC AND EPIGENETIC ALTERATIONS OF Polipalli Sunil K. STRATEGY TREATMENT OF SURGICAL
RESECTION INCREASES THE SURVIVAL
P16 & RASSF1A GENE IN HEPATOCELLULAR
POSTER BOARDS CARCINOMA FROM NORTH INDIA C89 RATE OF SELECTED HEPATOCELLULAR Lin Chih-Wen POSTER BOARDS
C80
CARCINOMA PATIENTS IN BARCELONA
HBV DNA INTEGRATION IN PATIENTS
CLINIC LIVER CANCER STAGE C
WITH OCCULT HBV INFECTION AND
C81
HEPATOCELLULAR CARCINOMA Saitta Carlo NAFLD-ASSOCIATED HEPATOCELLULAR
C90 CARCINOMA IN CIRRHOTIC AND NON- Oliveira Claudia P.
SURVEILLANCE OF HEPATOCELLULAR
C82 CARCINOMA: HOW IT WORKS IN CENTRAL Skladany Lubomir CIRRHOTIC PATIENTS IN BRAZIL
SLOVAKIA CHALLENGES FACING BCLC THERAPEUTIC
CARCINOVIC STUDY: CLINICAL COURSE C91 ALGORITHM IN TREATMENT OF 1437 El Fouly Amr
AND RADIOLOGICAL FEATURES OF EGYPTIAN HEPATOCELLULAR CARCINOMA
C83 Gelu-Simeon Moana
HEPATOCELLULAR CARCINOMA IN HIV/HCV PATIENTS
CO-INFECTED PATIENTS
NEUTROPHIL-TO-LYMPHOCYTE RATIO:
HEPATOCELLULAR CARCINOMA SCREENING A GOOD PREDICTOR OF DROP OUT IN
IS INDICATED EVEN AFTER SUSTAINED C92 HEPATOCELLULAR CANCER PATIENTS Lai Quirino
C84 Cherradi Younès
VIROLOGICAL RESPONSE:-MOROCCAN WAITING FOR LIVER TRANSPLANTATION
UNIVERSITY HOSPITAL EXPERIENCE-
EFFECT OF LEPTIN ADMINISTRATION
INTRATUMORAL INJECTION OF ON ETHANOL INDUCED APOPTOSIS
S-NITROSO-N-ACETYLCYSTEINE (SNAC) C93 AND FIBROGENESIS IN THE MOUSE Vairappan Balasubramaniyan
C85 IN A RODENT MODEL OF NON-ALCOHOLIC Oliveira Claudia P. HEPATOCELLULAR CARCINOMA CELL LINES
STEATOHEPATITIS (NASH)-RELATED
HEPATOCELLULAR CARCINOMA (HCC) FINAL ANALYSIS OF EUROPEAN SUBSET
OF GIDEON (GLOBAL INVESTIGATION
SPLENOSIS MIMICKING HEPATIC TUMOR: A Battista Levi
C86 Giovanni OF THERAPEUTIC DECISIONS IN
CASE REPORT Sandri
C94 HEPATOCELLULAR CARCINOMA AND OF Bronowicki Jean-Pierre
Battista Levi ITS TREATMENT WITH SORAFENIB [SOR])
C87 SURGERY IN LIVER HAEMANGIOMA Giovanni
Sandri IN SOR-TREATED PATIENTS (PTS): CLINICAL
FINDINGS IN PTS WITH LIVER DYSFUNCTION
   35   36   37   38   39   40   41   42   43   44   45